iBio, Inc. (IBIO) Social Stream



iBio, Inc. (IBIO): $1.90

0.12 (+6.74%)

POWR Rating

Component Grades

Momentum

D

Stability

F

Sentiment

Quality

D

Add IBIO to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#234 of 360

in industry

IBIO INC (IBIO) Price Targets From Analysts

Use the tables below to see what analysts covering IBIO INC think about its future price and what recommendations they have for investors and traders.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-10-04 1 $3 $3 $3 $1.35 122.22%
2021-11-29 2 $3 $1.5 $2.25 $1.35 66.67%
2022-06-06 2 $2.5 $1.5 $2 $1.35 48.15%
2022-10-07 2 $37.5 $4.25 $20.875 $1.35 1446.3%
2022-10-11 2 $4.5 $4.5 $4.5 $1.35 233.33%
2022-12-21 1 $0.5 $0.5 $0.5 $1.35 -62.96%
2023-02-16 1 $1 $1 $1 $1.35 -25.93%

The Trend in the Analyst Price Target


IBIO's average price target has moved down $2 over the prior 17 months.

500 - Internal server error

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-02-16 1 1 1 1 0.75 33.33%

IBIO Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
3 0 0 1 0 0 1

The Trend in the Broker Recommendations


IBIO's average broker recommendation rating worsened by 2 over the prior 35 weeks.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • IBIO has a higher number of analysts covering the stock than 16.98% of all US stocks.
  • To contextualize these metrics, consider that out of all US stocks, IBIO INC's average analyst price target is greater than 64.1% of them.
  • In terms of how IBIO INC fares relative to stocks in the small market cap category, note that its variance in analysts' estimates is lower than -218.65% of that group.
  • In the context of stocks in the small market cap category, IBIO INC's upside potential (average analyst target price relative to current price) is greater than 539.8% of them.

In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to IBIO INC are AMPE, VTGN, and CRMD.

What is the outlook for IBIO? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!